Medication info
Olmesartan Medoxomil 20 mg Tablets

Olmesartan Medoxomil 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201100902 · Approved 2011.02.24 · Insurance code 640902300

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be coadministered with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is monitored carefully. <Elderly patients> No dose adjustment is required when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy and safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
<Children> The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication treats essential hypertension by lowering blood pressure, which reduces strain on the heart and blood vessels and helps prevent complications. These medications work by dilating blood vessels or controlling heart rate to stabilize blood pressure. It is effective when used in conjunction with consistent dosage and lifestyle improvements for blood pressure management. Used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be coadministered with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is monitored carefully. <Elderly patients> No dose adjustment is required when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy and safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

<Children> The safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any component of this drug, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver dysfunction, patients with biliary obstruction, and patients with lactose intolerance should not take this medication. Patients with low blood volume or sodium may experience low blood pressure at the start of treatment, so caution is needed; if low blood pressure occurs, the patient should be laid down, and normal saline should be administered if necessary. Patients with impaired kidney function, those who have received kidney transplants, patients with renal artery hypertension, patients at risk for hyperkalemia, and patients with aortic or mitral stenosis should be closely monitored when taking this medication. This medication may cause side effects such as dizziness, so care should be taken when performing hazardous activities like working at heights or driving. According to clinical trial results, this medication has generally been safely used, with most side effects being mild and transient, but occasionally symptoms like chest pain, peripheral edema, dizziness, abdominal pain, palpitations, skin rashes may appear. If serious gastrointestinal symptoms like chronic diarrhea or weight loss occur, this medication should be discontinued, and a doctor should be consulted. Caution is needed when taken with potassium-sparing diuretics or potassium supplements, as blood potassium levels may become dangerously high, and the blood pressure-lowering effect may be enhanced when combined with other antihypertensives. Co-administration with lithium formulations may increase lithium levels and result in toxicity, so it is not recommended to take this drug and lithium together. When taken with non-steroidal anti-inflammatory drugs, the risk of worsening renal function may increase, so regular hydration and kidney function tests are recommended. When using this medication with other drugs that act on the angiotensin system, blood pressure, kidney function, and electrolyte status should be closely monitored, and patients with diabetes or moderate to severe renal impairment should not use specific medications in combination. This medication may be passed into breast milk, so breastfeeding women should either discontinue breastfeeding or stop taking the medication. Safety and efficacy in children have not been sufficiently established, so caution is advised for their use. Elderly patients may have higher plasma concentrations of this medication than younger individuals, so caution is necessary during use. In the event of overdose, symptoms such as low blood pressure, palpitations, and bradycardia may occur, and appropriate treatment should be provided based on symptoms. Although carcinogenicity or genotoxicity have not been reported with long-term administration, there may be rare instances of chromosomal changes or immune system abnormalities, thus regular testing is recommended.

Side effects

  • Dizziness
  • Low back pain
  • Bronchitis
  • Increased creatine phosphokinase
  • Diarrhea
  • Headache
  • Hematuria
  • Hyperglycemia
  • Hypertriglyceridemia
  • Influenza-like symptoms
Show 43 more
  • Pharyngitis
  • Rhinitis
  • Sinusitis
  • Cough
  • Chest pain
  • Peripheral edema
  • Vertigo
  • Abdominal pain
  • Indigestion
  • Gastroenteritis
  • Nausea
  • Palpitations
  • Hypercholesterolemia
  • Dyslipidemia
  • Hyperuricemia
  • Arthralgia
  • Arthritis
  • Myalgia
  • Rash
  • Facial edema
  • Asthenia
  • Angioedema
  • Anaphylactic reaction
  • Vomiting
  • Chronic malabsorption syndrome
  • Mesenteric edema
  • Rhabdomyolysis
  • Hyperkalemia
  • Acute renal failure
  • Elevated serum creatinine
  • Hair loss
  • Pruritus
  • Urticaria
  • Autoimmune hepatitis
  • Positional dizziness
  • Palpitations
  • Hypertension
  • Elevated serum creatinine
  • Epistaxis
  • Upper respiratory tract infection
  • Asthma
  • Hypotension
  • Bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air or moisture from entering. The suitable storage temperature is a cool place between 1 degrees and 25 degrees.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.